Leukemia

Ivan Maillard, MD, PhD, has been appointed head of the division of hematologic malignancies at Memorial Sloan Kettering Cancer Center.

In this video, Daniel DeAngelo, MD, PhD, discusses a study presented at ASH Annual Meeting that examined the KOMET-007 study into the use of menin inhibitors in patients with acute myeloid leukemia.

In this video, Daniel DeAngelo, MD, PhD, discusses the results of a study presented at ASH Annual Meeting that examined the SAVE trial into the use of menin inhibitors in patients with leukemia.

In this video, Daniel DeAngelo, MD, PhD, discusses the results of a study presented at ASH Annual Meeting 2024 that examined the use of menin inhibitors in patients with leukemia.

In this video, Daniel DeAngelo, MD, PhD, discusses the results of a study presented at ASH Annual Meeting that examined the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute lymphoblastic leukemia.

In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition with a focus on leukemia, as well as Healio’s top headlines from the meeting.

Historically, Jae H. Park, MD, has not paid much attention to his patients’ weight loss.

In this video, Moath Albliwi, MD, discusses the results of a study he co-presented at ASH Annual Meeting and Exposition that examined treatment of elderly patients with acute myeloid leukemia.

SAN DIEGO — A multidrug combination significantly improved survival for certain patients with leukemia compared with standard chemoimmunotherapy, according to results of the randomized phase 3 AMPLIFY study.

SAN DIEGO — The increased use of AI in health care has generated tremendous excitement for its potential to guide treatment decision-making, improve outcomes and increase efficiency.